Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm

Gorter, Petra M; Olijhoek, Jobien K; van der Graaf, Yolanda; Algra, Ale; Rabelink, Ton J; Visseren, Frank L.J

doi:10.1016/j.atherosclerosis.2003.12.033

Cited by 216Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm

Gorter, Petra M, Olijhoek, Jobien K, van der Graaf, Yolanda, Algra, Ale, Rabelink, Ton J, Visseren, Frank L.J·2004·Atherosclerosis

DOI 10.1016/j.atherosclerosis.2003.12.033

Open this paper in CoChat — free account

Abstract

Metabolic syndrome patients are at increased risk for developing cardiovascular morbidity and mortality. The increasing prevalence of the metabolic syndrome in various asymptomatic populations has been well documented, however, limited information is available about the prevalence in manifest atherosclerotic vascular disease patients. The aim of this study is to determine the overall and gender-specific prevalence of the metabolic syndrome and its components in these patients. This cross-sectional survey of 1117 patients, aged 18-80 years, mean age 60+/-10 years, comprised patients with coronary heart disease (n=527), cerebrovascular disease (n=258), peripheral arterial disease (n=232) or abdominal aortic aneurysm (n=100). Metabolic syndrome was defined by Adult Treatment Panel III. The prevalence of the metabolic syndrome in the study population was 46%: 58% in PAD patients, 41% in CHD patients, 43% in CVD patients and 47% in AAA patients. Overall, women had a higher prevalence than men (56% versus 43%). Age did not influence the metabolic syndrome prevalence; crude odds ratios (crude OR) 1.00 (95% CI: 0.99-1.02). Our results demonstrate a high prevalence of the metabolic syndrome in patients with manifest atherosclerotic vascular disease. Screening for metabolic syndrome in patients with high risk for new vascular incidents may identify patients with even higher vascular risk and may direct anti-atherosclerotic treatment in order to prevent new vascular incidents in the same or another vascular bed.

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2003.12.033

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

MetS is present in approximately 50% of patients with diagnosed vascular disease and may be even more prevalent among women with ASCVD.
“MetS is present in w50% of patients with diagnosed vascular disease and may be even more prevalent among women with ASCVD (10,11).”
From The CardioMetabolic Health Alliance (2015) · cites this paper as [10]

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works
Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698 · see citing works
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · see citing works
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760 · see citing works
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292 · see citing works
NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475 · see citing works
A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions
Ford, E. S., & Giles, W. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.575 · Cited by 616 · see citing works
Clustering of Procoagulation, Inflammation, and Fibrinolysis Variables with Metabolic Factors in Insulin Resistance Syndrome
Sakkinen, P. A., WAHL, P. W., Cushman, M., Lewis, M. R., & Tracy, R. P. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.897 · Cited by 420 · see citing works
Syndrome X and Mortality: A Population-based Study
Trevisan, M., Liu, J., Bahsas, F. B., & Menotti, A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009572 · Cited by 389 · see citing works
Development of the Multiple Metabolic Syndrome: An Epidemiologic Perspective
Liese, A. D., Mayer‐Davis, E. J., & Haffner, S. M. (1998) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017978 · Cited by 375 · see citing works
Second Manifestations of ARTerial disease (SMART) study: Rationale and design
Simons, P. C. G., Algra, A., van der Laak, M. F., Grobbee, D. E., & van der Graaf, Y. (1999) · European Journal of Epidemiology · doi:10.1023/a:1007621514757 · Cited by 366 · see citing works
Self-citation
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
Garg, J. P., & Bakris, G. L. (2002) · Vascular Medicine · doi:10.1191/1358863x02vm412ra · Cited by 276 · see citing works
The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes
Isomaa, B., Henricsson, M., Almgren, P.-E., Tuomi, T., Taskinen, M., & Groop, L. (2001) · Diabetologia · doi:10.1007/s001250100615 · Cited by 258 · see citing works
Elevated Urinary Albumin Excretion Is Associated With Impaired Arterial Dilatory Capacity in Clinically Healthy Subjects
Clausen, P., Jensen, J. S., JENSEN, G. F., Borch‐Johnsen, K., & Feldt‐Rasmussen, B. (2001) · Circulation · doi:10.1161/01.cir.103.14.1869 · Cited by 231 · see citing works
Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects
Rantala, A. O., Kauma, H., Lilja, M., Savolainen, M. J., Reunanen, A., & Kesäniemi, Y. A. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00429.x · Cited by 211 · see citing works
Development of the multiple metabolic syndrome in the ARIC cohort: Joint contribution of insulin, BMI, and WHR
Liese, A. D., Mayer‐Davis, E. J., Tyroler, H. A., DAVIS, C. E., Keil, U., Duncan, B. B., & HEISS, G. M. (1997) · Annals of Epidemiology · doi:10.1016/s1047-2797(97)00047-1 · Cited by 104 · see citing works
Untitled work
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7

Flagged first, then by citations

Sorted by citations

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170 · see citing works
Metabolic Syndrome Pandemic
Grundy, S. M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.151092 · Cited by 1,571 · see citing works
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
Furie, K. L., Kasner, S. E., Adams, R. J., Albers, G. W., Bush, R. L., Fagan, S. C., Halperin, J. L., Johnston, S. C., Katzan, I. L., Kernan, W. N., et al. (2010) · Stroke · doi:10.1161/str.0b013e3181f7d043 · Cited by 1,492 · see citing works
Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study
Ray, J. G., Vermeulen, M. J., Schull, M. J., & Redelmeier, D. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67726-4 · Cited by 1,013 · see citing works
Epidemiology, classification, and modifiable risk factors of peripheral arterial disease
Shammas, N. W. (2007) · Vascular Health and Risk Management · doi:10.2147/vhrm.2007.3.2.229 · Cited by 315 · see citing works
The CardioMetabolic Health Alliance
Sperling, L. S., Mechanick, J. I., Neeland, I. J., Herrick, C. J., Després, J.-P., Ndumele, C. E., Vijayaraghavan, K., Handelsman, Y., Puckrein, G. A., Araneta, M. R. G., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1328 · Cited by 294 · see citing works
Low-density lipoprotein size and cardiovascular risk assessment
Rizzo, M., & Berneis, K. K. (2005) · QJM · doi:10.1093/qjmed/hci154 · Cited by 257 · see citing works
The Prevalence of Metabolic Syndrome in Various Populations
Kolovou, G. D., Anagnostopoulou, K. K., Salpea, K. D., & Mikhailidis, D. P. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318065c3a1 · Cited by 248 · see citing works
Pathophysiology of dyslipidaemia in the metabolic syndrome
Kolovou, G. D., Anagnostopoulou, K. K., & Cokkinos, D. V. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.025601 · Cited by 212 · see citing works
Abdominal obesity: The most prevalent cause of the metabolic syndrome and related cardiometabolic risk
Després, J.-P. (2006) · European Heart Journal Supplements · doi:10.1093/eurheartj/sul002 · Cited by 205 · see citing works
Relation Between the Metabolic Syndrome and Ischemic Stroke or Transient Ischemic Attack
Koren‐Morag, N., Goldbourt, U., & Tanné, D. (2005) · Stroke · doi:10.1161/01.str.0000169945.75911.33 · Cited by 175 · see citing works
Traditional and Novel Risk Factors for Clinically Diagnosed Abdominal Aortic Aneurysm: The Kaiser Multiphasic Health Checkup Cohort Study
Iribarren, C., Darbinian, J. A., Go, A. S., FIREMAN, B. H., Lee, C. D., & Grey, D. P. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.02.004 · Cited by 167 · see citing works
Association of the metabolic syndrome with intracranial atherosclerotic stroke
Bang, O. Y., Kim, J. W., Lee, J. H., Lee, M. A., Lee, P. H., Joo, I. S., & Huh, K. H. (2005) · Neurology · doi:10.1212/01.wnl.0000168862.09764.9f · Cited by 146 · see citing works
Prevalência de síndrome metabólica em estudo de base populacional, Vitória, ES - Brasil
Salaroli, L. B., Barbosa, G. C., Mill, J. G., & Molina, M. C. B. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000700018 · Cited by 137 · see citing works
Vascular biology of metabolic syndrome
Vykoukal, D. M., & Davies, M. G. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.01.003 · Cited by 128 · see citing works
Components of the Metabolic Syndrome and Risk for First-Ever Acute Ischemic Nonembolic Stroke in Elderly Subjects
Milionis, H. J., Rizos, E. C., Goudevenos, J. A., Seferiadis, K. I., Mikhailidis, D. P., & Elisaf, M. (2005) · Stroke · doi:10.1161/01.str.0000169935.35394.38 · Cited by 123 · see citing works
Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel
Shepherd, J., Betteridge, J. D., Gaal, L. V., & Panel, O. B. O. A. E. C. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x43677 · Cited by 100 · see citing works
Novel events in the molecular regulation of muscle mass in critically ill patients
Constantin, D., McCullough, J., Mahajan, R. P., & Greenhaff, P. L. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.206193 · Cited by 100 · see citing works
“The long-term impairment of muscle CHO oxidation by PDK4 has been implicated as a causative factor in muscle insulin resistance (Gorter et al. 2004).”
Background
Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm
Wassink, A. M. J., van der Graaf, Y., Olijhoek, J. K., Visseren, F. L. J., & for the SMART Study Group (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm582 · Cited by 94 · see citing works
Self-citation
Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome
Hajer, G. R., van der Graaf, Y., Olijhoek, J. K., Verhaar, M. C., Visseren, F. L. J., & for the SMART Study Group (2005) · Heart · doi:10.1136/hrt.2006.093971 · Cited by 88 · see citing works
Self-citation
Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication
Golledge, J., Leicht, A. S., Crowther, R. G., Clancy, P., Spinks, W. L., & Quigley, F. G. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.09.006 · Cited by 85 · see citing works
Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis
Ovbiagele, B. I., Saver, J. L., Lynn, M., & Chimowitz, M. I. (2006) · Neurology · doi:10.1212/01.wnl.0000210530.46058.5c · Cited by 78 · see citing works
Who needs to care about small, dense low-density lipoproteins?
Rizzo, M., & Berneis, K. K. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01596.x · Cited by 77 · see citing works
Impact of metabolic syndrome in surgical patients: should we bother?
Tzimas, P. G., Petrou, A., Laou, E., Milionis, H. J., Mikhailidis, D. P., & Papadopoulos, G. (2015) · British Journal of Anaesthesia · doi:10.1093/bja/aev199 · Cited by 75 · see citing works
MR plaque imaging of the carotid artery
Watanabe, Y., & Nagayama, M. (2010) · Neuroradiology · doi:10.1007/s00234-010-0663-z · Cited by 72 · see citing works
Cardiometabolic Risk and Female Sexuality—Part I. Risk Factors and Potential Pathophysiological Underpinnings for Female Vasculogenic Sexual Dysfunction Syndromes
Maseroli, E., Scavello, I., & Vignozzi, L. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.02.009 · Cited by 72 · see citing works
Cancer Risk in Patients with Manifest Vascular Disease: Effects of Smoking, Obesity, and Metabolic Syndrome
van Kruijsdijk, R. C. M., van der Graaf, Y., Peeters, P. H. M., Visseren, F. L. J., & on behalf of the Second Manifestations of ARTerial disease (SMART) study group (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0090 · Cited by 72 · see citing works
“MetS, as well as other established risk factors for cancer such as obesity and smoking, are highly prevalent in patients with vascular disease(19).”
BackgroundSelf-citation
Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus.
Bultink, I. E. M., Turkstra, F., Diamant, M., Dijkmans, B. A. C., & Voskuyl, A. E. (2008) · PubMed · Cited by 70 · see citing works
Impact of C-Reactive Protein on the Likelihood of Peripheral Arterial Disease in United States Adults With the Metabolic Syndrome, Diabetes Mellitus, and Preexisting Cardiovascular Disease
Vu, J. D., Vu, J. B., Pio, J. R., Malik, S., Franklin, S. S., Chen, R. S., & Wong, N. D. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.04.038 · Cited by 66 · see citing works
The Role of FOXO and PPAR Transcription Factors in Diet-Mediated Inhibition of PDC Activation and Carbohydrate Oxidation During Exercise in Humans and the Role of Pharmacological Activation of PDC in Overriding These Changes
Constantin‐Teodosiu, D., Constantin, D., Stephens, F. B., Laithwaite, D., & Greenhaff, P. L. (2012) · Diabetes · doi:10.2337/db11-0799 · Cited by 65 · see citing works
Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events
Mani, V., Muntner, P., Gidding, S. S., Aguiar, S., Aidi, H. E., Weinshelbaum, K. B., Taniguchi, H., van der Geest, R. J., Reiber, J. H. C., Bansilal, S., et al. (2009) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-11-10 · Cited by 64 · see citing works
“It is also known that patients with prior major cardiovascular and cerebrovascular events (MACE) are at increased risk for recurrent events independent of other risk factors [8-10].”
A comparison of 12 weeks of pilates and aquatic training on the dynamic balance of women with mulitple sclerosis.
Kazemi, T., Sharifzadeh, G., Zarban, A., & Fesharakinia, A. (2013) · Europe PMC (PubMed Central) · Cited by 62 · see citing works
miR-182 Regulates Metabolic Homeostasis by Modulating Glucose Utilization in Muscle
Zhang, D., Li, Y., Yao, X., Wang, H. J., Zhao, L., Jiang, H., Yao, X., Zhang, S., Cheng, Y., Liu, W., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.040 · Cited by 62 · see citing works
Women and peripheral arterial disease: same disease, different issues
Brevetti, G., Bucur, R., Balbarini, A., Melillo, E., Novo, S., Muratori, I. M., & Massimo Chiariello, A. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3282f03b90 · Cited by 60 · see citing works
Total, direct, and indirect serum bilirubin concentrations and metabolic syndrome among the Korean population
Jo, J., Yun, J. E., Hee-Yeon, L., Kimm, H., & Jee, S. H. (2010) · Endocrine · doi:10.1007/s12020-010-9417-2 · Cited by 59 · see citing works
High prevalence of metabolic syndrome among young women with premature coronary artery disease
Turhan, H., Yaşar, A. S., Başar, N., Biçer, A., Erbay, A. R., & Yetkın, E. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200502000-00007 · Cited by 57 · see citing works
Prevalence and correlates of metabolic syndrome (MS) in older adults
Cankurtaran, M., Halil, M. G., Doğu, B. B., Dağlı, N., Oyan, B., & Arıoğul, S. (2005) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2005.05.004 · Cited by 59 · see citing works
Subclinical atherosclerosis, cardiovascular health, and disease risk: is there a case for the Cardiovascular Health Index in the primary prevention population?
Singh, S. S., Pilkerton, C. S., Shrader, C. D., & Frisbee, S. J. (2018) · BMC Public Health · doi:10.1186/s12889-018-5263-6 · Cited by 53 · see citing works
Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity
Brevetti, G., Schiano, V., Sirico, G., Giugliano, G., Laurenzano, E., & Chiariello, M. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.02.048 · Cited by 55 · see citing works
Metabolic Syndrome and Non-Cardiac Vascular Diseases: An Update from Human Studies
Katsiki, N., Athyros, V. G., Karagiannis, A. I., & Mikhailidis, D. P. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612819666131206100750 · Cited by 52 · see citing works
Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial
Daly, C., Hildebrandt, P. R., Bertrand, M. E., Ferrari, R., Remme, W. J., Simoons, M. L., & Fox, K. M. (2007) · Heart · doi:10.1136/hrt.2006.113084 · Cited by 50 · see citing works
Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization
Protack, C. D., Bakken, A. M., Xu, J., Saad, W. A., Lumsden, A. B., & Davies, M. G. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2008.12.011 · Cited by 49 · see citing works
Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies
Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2004) · Clinical Science · doi:10.1042/cs20040108 · Cited by 48 · see citing works
Apolipoprotein E4 association with metabolic syndrome depends on body fatness
Torres-Pérez, E., Ledesma, M., García-Sobreviela, M. P., León-Latre, M., & Arbonés-Mainar, J. M. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.11.029 · Cited by 45 · see citing works
Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study
Verhagen, S. N., Wassink, A. M. J., van der Graaf, Y., Gorter, P. M., Visseren, F. L. J., & the SMART Study Group (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-100 · Cited by 39 · see citing works
“Metabolic syndrome is highly prevalent in patients with manifest arterial disease (46%)[15] and is associated with advanced vascular damage [16], thereby identifying those patients with an even higher cardiovascular risk.”
Self-citation
Dethrombosis of the Lower Extremity Arteries Using the Power-Pulse Spray Technique in Patients with Recent Onset Thrombotic Occlusions: Results of the DETHROMBOSIS Registry
Shammas, N. W., Dippel, E. J., Shammas, G. A., Gayton, L., Coiner, D., & Jerin, M. J. (2008) · Journal of Endovascular Therapy · doi:10.1583/08-2453.1 · Cited by 39 · see citing works
Glycemic Control during Coronary Artery Bypass Graft Surgery
Lazar, H. L. (2012) · ISRN Cardiology · doi:10.5402/2012/292490 · Cited by 37 · see citing works
A Prospective Study on the Prevalence of Metabolic Syndrome Among Healthy French Families
Maumus, S., Bastien, B., Siest, G., & Visvikis‐Siest, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.675 · Cited by 36 · see citing works
Prognostic Relevance of Metabolic Syndrome in Hypertensive Patients at Low-to-Medium Risk
Pierdomenico, S. D., Lapenna, D., DITOMMASO, R., DiCarlo, S. E., CALDARELLA, M., Neri, M., Mezzetti, A., & CUCCURULLO, F. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.06.011 · Cited by 35 · see citing works
Metabolic syndrome is an independent predictor of cardiovascular events in high-risk patients with occlusive and aneurysmatic peripheral arterial disease.
van Kuijk, J., Flu, W., Chonchol, M., Bax, J. J., Verhagen, H., & Poldermans, D. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.018 · Cited by 34 · see citing works
Premature Coronary Heart Disease, Cigarette Smoking, and the Metabolic Syndrome
Tonstad, S., & Svendsen, M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.083 · Cited by 33 · see citing works
Impact of Metabolic Syndrome on Atherosclerotic Burden and Cardiovascular Prognosis
Espinola–Klein, C., Rupprecht, H. J., Bickel, C., Post, F., Genth‐Zotz, S., Lackner, K. J., Münzel, T. F., & Blankenberg, S. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.01.049 · Cited by 33 · see citing works
Differential Impact of Dilator Stimuli on Increased Myogenic Activation of Cerebral and Skeletal Muscle Resistance Arterioles in Obese Zucker Rats
Butcher, J. T., Goodwill, A. G., Stanley, S., & Frisbee, J. C. (2013) · Microcirculation · doi:10.1111/micc.12056 · Cited by 32 · see citing works
Adherence to a Mediterranean lifestyle improves metabolic status in coronary heart disease patients: A prospective analysis from the CORDIOPREV study
Romero‐Cabrera, J. L., García‐Ríos, A., Sotos‐Prieto, M., Quintana‐Navarro, G. M., Alcala-Diaz, J. F., Martín‐Piedra, L., Torres-Peña, J. D., Luque, R. M., Yubero‐Serrano, E. M., Delgado‐Lista, J., et al. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13602 · Cited by 32 · see citing works
The effect of leisure-time physical activity on the presence of metabolic syndrome in patients with manifest arterial disease. The SMART study
Brouwer, B. G., Visseren, F. L. J., & van der Graaf, Y. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.031 · Cited by 32 · see citing works
Self-citation
The Relationship of Peripheral Arterial Disease and Metabolic Syndrome Prevalence in Asymptomatic US Adults 40 Years and Older: Results From the National Health and Nutrition Examination Survey (1999–2004)
Sumner, A. D., Khalil, Y. K., & REED, J. F. (2012) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00580.x · Cited by 31 · see citing works
ChREBP binding and histone modifications modulate hepatic expression of the Fasn gene in a metabolic syndrome rat model
Suzuki, T., Muramatsu, T., Morioka, K., Goda, T., & Mochizuki, K. (2015) · Nutrition · doi:10.1016/j.nut.2015.01.005 · Cited by 29 · see citing works
Metabolic syndrome and coronary heart disease risk in a population-based study of middle-aged men from France and Northern Ireland
Bataille, V., Perret, B., Dallongeville, J., Arveiler, D., Yarnell, J., Ducimetière, P., & Ferrières, J. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70306-3 · Cited by 29 · see citing works
Relationship between Peripheral Arterial Disease and Metabolic Syndrome
Maksimović, M., Vlajinac, H., Radak, D. J., Marinković, J., & Jorga, J. B. (2009) · Angiology · doi:10.1177/0003319708325445 · Cited by 29 · see citing works
Partial Peroxisome Proliferator-Activated Receptor Agonist Angiotensin Receptor Blockers
Towfighi, A., & Ovbiagele, B. I. (2008) · Cerebrovascular Diseases · doi:10.1159/000139656 · Cited by 27 · see citing works
“Indeed a group of abnormalities, including visceral obesity, insulin resistance, dyslipidemia and elevated blood pressure, collectively termed the metabolic syndrome, has been associated with prothrombotic, proatherogenic and inflammatory risk factors that predispose to atherosclerotic vascular disease, including stro…”
Background
Optimizing management of metabolic syndrome to reduce risk: focus on life-style
Bianchi, C., Penno, G., Daniele, G., Benzi, L., Prato, S. D., & Miccoli, R. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0122-6 · Cited by 28 · see citing works
“In addition, a high prevalence of the MS (46%) was recently reported in patients with atherosclerotic disease (coronary heart disease, cerebrovascular disease, peripheral artery disease, or abdominal aortic aneurysm) [82].”
Background
The prevalence of the metabolic syndrome components and their combinations in men and women with acute ischemic syndromes
Žaliūnas, R., Šlapikas, R., Babarskienė, R. M., Šlapikienė, B., Lukšienė, D., Milvidaitė, I., & Laukaitienė, J. (2008) · Medicina · doi:10.3390/medicina44070067 · Cited by 28 · see citing works
PPARδ agonism inhibits skeletal muscle PDC activity, mitochondrial ATP production and force generation during prolonged contraction
Constantin‐Teodosiu, D., Baker, D. J., Constantin, D., & Greenhaff, P. L. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.164210 · Cited by 27 · see citing works
Rs964184 (APOA5-A4-C3-A1) Is Related to Elevated Plasma Triglyceride Levels, but Not to an Increased Risk for Vascular Events in Patients with Clinically Manifest Vascular Disease
van de Woestijne, A. P., van der Graaf, Y., de Bakker, P. I. W., Asselbergs, F. W., Spiering, W., Visseren, F. L. J., & for the SMART Study Group (2014) · PLoS ONE · doi:10.1371/journal.pone.0101082 · Cited by 27 · see citing works
Self-citation
Evidence-based management of peripheral vascular disease
Shammas, N. W., & Dippel, E. J. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0047-8 · Cited by 26 · see citing works
Metabolic syndrome and preclinical atherosclerosis: focus on femoral arteries
Vaudo, G., Marchesi, S., Siepi, D., Brozzetti, M., Mannarino, M. R., Pirro, M., Schillaci, G., Ciuffetti, G., Lupattelli, G., & Mannarino, E. (2007) · Metabolism · doi:10.1016/j.metabol.2006.11.016 · Cited by 26 · see citing works
“More recently, in a large-cross sectional study, it has been documented that metabolic syndrome is more prevalent in patients affected by peripheral arterial disease than in patients with coronary and cerebrovascular atherosclerosis [4].”
Background
Integrity of venoarteriolar reflex determines level of microvascular skin flow enhancement with intermittent pneumatic compression
Husmann, M. J. W., Willenberg, T., Keo, H. H., Spring, S., Kalodiki, E., & Delis, K. T. (2008) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2008.07.016 · Cited by 26 · see citing works
Metabolomic study of plasma of patients with abdominal aortic aneurysm
Rupérez, F. J., Ramos‐Mozo, P., Teul, J., Martínez-Pinna, R., Garcı́a, A., Malet‐Martino, M., Camafeita, E., López, J. A., Pastor‐Vargas, C., Egido, J., et al. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-5982-y · Cited by 26 · see citing works
Correlation analysis of metabolic syndrome and its components with thyroid nodules
Liu, J., Wang, C., Tang, X., Fu, S., Jing, G., Ma, L., Sun, W., Li, Y., Wu, D., Niu, Y., et al. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s219019 · Cited by 25 · see citing works
How Important is Glycemic Control During Coronary Artery Bypass?
Lazar, H. L. (2012) · Advances in Surgery · doi:10.1016/j.yasu.2012.03.007 · Cited by 23 · see citing works
Metabolic Syndrome with Hyperglycemia and the Risk of Ischemic Stroke
Li, M., Li, Y., & Liu, J. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2013.54.2.283 · Cited by 22 · see citing works
Socioeconomic Position, Comorbidity, and Mortality in Aortic Aneurysms: A 13-Year Prospective Cohort Study
Ohrlander, T., Merlo, J., Ohlsson, H., Sonesson, B., & Acosta, S. (2011) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2011.08.003 · Cited by 21 · see citing works
Hemorheology, ankle brachial pressure index (ABPI) and toe brachial pressure index (TBPI) in metabolic syndrome
Gyawali, P., Richards, R. S., Tinley, P., & Nwose, E. U. (2014) · Microvascular Research · doi:10.1016/j.mvr.2014.06.013 · Cited by 21 · see citing works
Sustained release nitrite therapy results in myocardial protection in a porcine model of metabolic syndrome with peripheral vascular disease
Bradley, J., Islam, K. N., Polhemus, D. J., Donnarumma, E., Brewster, L. P., Tao, Y., Goodchild, T. T., & Lefer, D. J. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00163.2015 · Cited by 20 · see citing works
Perioperative glycemic control in diabetic patients undergoing coronary artery bypass graft surgery
Wahby, E., Elnasr, M. A., Eissa, M. I., & Mahmoud, S. M. (2016) · Journal of the Egyptian Society of Cardio-Thoracic Surgery · doi:10.1016/j.jescts.2016.05.007 · Cited by 21 · see citing works
Clinical impact of exercise in patients with peripheral arterial disease
Novaković, M., Jug, B., & Lenasi, H. (2016) · Vascular · doi:10.1177/1708538116678752 · Cited by 21 · see citing works
“Results from several studies, in which patients exhibiting both PAD and MetS were included, report that prevalence of MetS in patients with PAD range from 52% to 58%.(114,115) Patients with PAD, who have MetS, have increased risk of cardiovascular events,(112) limited quality of life(116) and walking performance,(112,…”
Background
Intra-abdominal fat and metabolic syndrome are associated with larger infrarenal aortic diameters in patients with clinically evident arterial disease
Gorter, P. M., Visseren, F. L. J., Moll, F. L., & van der Graaf, Y. (2008) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2008.02.020 · Cited by 21 · see citing works
Self-citation
Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients
Vlek, A. L. M., van der Graaf, Y., Spiering, W., Visseren, F. L. J., & SMART study group (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.5 · Cited by 21 · see citing works
“10 and 45p in patients with clinical manifestations of atherosclerosis”
BackgroundSelf-citation
Therapeutic potential of sustained-release sodium nitrite for critical limb ischemia in the setting of metabolic syndrome
Polhemus, D. J., Bradley, J., Islam, K. N., Brewster, L. P., Calvert, J. W., Tao, Y., Chang, C. C., Pipinos, I. I., Goodchild, T. T., & Lefer, D. J. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00115.2015 · Cited by 19 · see citing works
Multimodality Stroke Prevention
Sanossian, N., & Ovbiagele, B. I. (2006) · The Neurologist · doi:10.1097/01.nrl.0000186808.07659.c7 · Cited by 20 · see citing works
“It has also been shown that there is a high prevalence of the metabolic syndrome in patients with manifest atherosclerotic vascular disease.(60) The syndrome is composed of glucose intolerance/ insulin resistance, central abdominal adiposity, elevated blood pressure, and dyslipidemias such as low HDL cholesterol and h…”
Background
Metabolic syndrome and vascular risk in patients with peripheral arterial occlusive disease
Vlek, A. L. M., van der Graaf, Y., Sluman, M. A., Moll, F. L., & Visseren, F. L. J. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2008.12.070 · Cited by 19 · see citing works
Self-citation
Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study
Maksimović, M., Vlajinac, H., Radak, D. J., Marinković, J., & Jorga, J. B. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-2 · Cited by 19 · see citing works
Comparison of Cardiovascular Risk Factors for Peripheral Artery Disease and Coronary Artery Disease in the Korean Population
Jang, S. Y., Ju, E. Y., Cho, S., Lee, S. W., & Kim, D. (2013) · Korean Circulation Journal · doi:10.4070/kcj.2013.43.5.316 · Cited by 19 · see citing works
The metabolic syndrome among patients with cardiovascular disease in Accra, Ghana.
Akpalu, J., Akpalu, A. K., & Ofei, F. (2011) · PubMed Central · Cited by 18 · see citing works
The influence of metabolic syndrome on hemodialysis access patency
Protack, C. D., Jain, A., Vasilas, P., & Dardik, A. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2012.05.104 · Cited by 18 · see citing works
Chronic kidney disease predicts long-term mortality after major lower extremity amputation
Dardik, A., Assi, R., Azzi, Y. A., Protack, C. D., Williams, W. T., Hall, M. R., Wong, D., Lu, D. Y., & Vasilas, P. (2014) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.136910 · Cited by 17 · see citing works
ROmanian multicentric study of the prevalence of metabolic syndrome--ROMES.
Matei, C., Pop, I., Jurcut, R. O., Suceveanu, M., Predescu, D., Nechita, E. L., Ionescu, P., Ciovica, D., & Ginghină, C. (2008) · PubMed · Cited by 17 · see citing works
Protection of diabetes in aortic abdominal aneurysm: Are antidiabetics the real effectors?
Picatoste, B., Cerro-Pardo, I., Blanco‐Colio, L. M., & Martı́n-Ventura, J. L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1112430 · Cited by 16 · see citing works
Prevalence of Metabolic Syndrome in Patients With Intermittent Claudication and its Correlation With the Segment of Arterial Obstruction
Zerati, A. E., Wolosker, N., Rosoky, R. A., Saes, G. F., Ragazzo, L., & Puech‐Leão, P. (2010) · Angiology · doi:10.1177/0003319710366127 · Cited by 16 · see citing works
Metabolic Syndrome but not Obesity Adversely Affects Outcomes after Open Aortoiliac Bypass Surgery
Tanaka, A., Perlick, A. P., Miller, C. C., Sandhu, H. K., Afaq, S., Safi, H. J., Azizzadeh, A., & Charlton-Ouw, K. M. (2017) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2017.08.011 · Cited by 16 · see citing works
Prevalence of Metabolic Syndrome in Patients With Clinically Advanced Peripheral Vascular Disease
Qadan, L. R., Ahmed, A. A., Safar, H. A., Al-Bader, M. A., & Ali, A. (2008) · Angiology · doi:10.1177/0003319707304582 · Cited by 15 · see citing works
Estudio de prevalencia de la enfermedad arterial periférica y diabetes en España
Puras-Mallagray, E., Gutiérrez-Baz, M., Cáncer-Pérez, S., Alfayate-García, J. M., de Benito-Fernández, L., Perera-Sabio, M., Galán, F. C., & Hernández‐Mijares, A. (2008) · Angiología · doi:10.1016/s0003-3170(08)05001-3 · Cited by 15 · see citing works
“En el estudio SMART [17], Gorter et al, encontra-ron que el síndrome metabólico estaba presente en el 58% de los pacientes con EAP, cifra muy parecida a la ofrecida por nuestro trabajo.”
Cryoballoon Angioplasty Broadens the Role of Primary Angioplasty and Reduces Adjuvant Stenting in Complex Superficial Femoral Artery Lesions
Bakken, A. M., Saad, W. E. A., & Davies, M. G. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.09.008 · Cited by 15 · see citing works
High total-to-HDL cholesterol ratio predicting deterioration of ankle brachial index in Asian type 2 diabetic subjects
Lee, I., Huang, C., Lee, W., Lee, H., & Sheu, W. H. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.10.002 · Cited by 15 · see citing works
Prevalence of metabolic syndrome and association with burden of atherosclerotic disease in patients with stable coronary artery disease
Varounis, C., Rallidis, L. S., Franco, O. H., & Lekakis, J. P. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1163257 · Cited by 15 · see citing works
Metabolic Syndrome Relates to Lacunar Stroke without White Matter Lesions: A Study in First-Ever Lacunar Stroke Patients
Zhang, C. E., van Raak, E. P. M., Rouhl, R. P. W., Lodder, J., Staals, J., Knottnerus, I. L. H., & van Oostenbrugge, R. J. (2010) · Cerebrovascular Diseases · doi:10.1159/000297967 · Cited by 14 · see citing works
“The prevalence of MetS in cardiovascular patients is high, up to 50p [ , , ,”
Background
Metabolic Syndrome and Homocysteine Level as Predictors of the Severity of Coronary Artery Disease in Patients With Carotid Stenosis
Hsieh, M., Chen, C., Lee, C.-H., Wen, M., Lin, F., Hsieh, I.-C., Wu, D., & Lee, T. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181ab1c96 · Cited by 14 · see citing works
Presence of the Metabolic Syndrome Does Not Impair Coronary Collateral Vessel Formation in Patients With Documented Coronary Artery Disease
Olijhoek, J. K., Koerselman, J., de Jaegere, P. P. T., Verhaar, M. C., Grobbee, D. E., van der Graaf, Y., Visseren, F. L. J., & for the SMART Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.3.683 · Cited by 14 · see citing works
Self-citation
Metabolic Syndrome in Polish Ischemic Stroke Patients
Brola, W., Sobolewski, P. K., Fudala, M., Goral, A. J., Kasprzyk, M., Szczuchniak, W., Pejas-Dulewicz, R., & Przybylski, W. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.06.003 · Cited by 14 · see citing works
Metabolic Syndrome Among Ethnic South Asian Patients With Ischemic Stroke and Comparison With Ethnic Chinese Patients: The Singapore General Hospital Experience
Silva, D. A. D., Woon, F. P., Xie, X. Y., Chen, C., Chang, H. M., & Wong, M. C. (2007) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2007.01.001 · Cited by 14 · see citing works

Metabolic Syndrome in Patients with Atherosclerotic Vascular Disease
Zaman, S. (2016) · DOAJ (DOAJ: Directory of Open Access Journals)
Prevalence of metabolic syndrome and association with burden of atherosclerotic disease in patients with stable coronary artery disease
Varounis, C., Rallidis, L. S., Franco, O. H., & Lekakis, J. P. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1163257 · Cited by 15 · see citing works
Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study
Athyros, V. G., Mikhailidis, D. P., Papageorgiou, A. A., Didangelos, T., Ganotakis, E. S., Symeonidis, A. N., Daskalopoulou, S. S., Kakafika, A. I., & Elisaf, M. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904x5599 · Cited by 82 · see citing works
Prevalence of Metabolic Syndrome and Diabetes on a High-Risk Population with Suspected Coronary Artery Disease Prevalência de Síndrome Metabólica e Diabetes numa População de Alto Risco com Suspeita de Doença Coronária
Timóteo, A. T., Carmo, M. M., & Ferreira, F. (2012)
Prevalence of metabolic syndrome and diabetes on a high-risk population with suspected coronary artery disease.
Timóteo, A. T., Carmo, M. M., & Ferreira, R. C. (2012) · PubMed · Cited by 5 · see citing works

Authors: Gorter, P. M., Olijhoek, J. K., van der Graaf, Y., Algra, A., Rabelink, T. J., & Visseren, F. L. J.
Affiliations: University Medical Center Utrecht (NL)
Corresponding author: Olijhoek, Jobien K
ORCID: Algra, Ale
Rabelink, Ton J
Visseren, Frank L.J
Venue: Atherosclerosis
Publisher: Elsevier BV
Published: 2004-04
Volume: 173
Issue: 2
Pages: 361-367
ISSN: 0021-9150 (ISSN-L)
DOI: 10.1016/j.atherosclerosis.2003.12.033
OpenAlex: W2020922372
Cited by: 216
References: 18
Citations by year: 2026: 2 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 5 · 2016: 11 · 2015: 15 · 2014: 12 · 2013: 10 · 2012: 13
FWCI: 12.28
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Atherosclerosis (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
Keywords: metabolic syndrome, prevalence, coronary artery disease, cerebrovascular disease, peripheral arterial disease, abdominal aortic aneurysm, atherosclerosis, sex differences, metabolic syndrome screening, cardiovascular risk
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Arterial Occlusive Diseases, Cerebrovascular Disorders, Coronary Disease, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Netherlands, Cohort Studies, Comorbidity, Prevalence, Multivariate Analysis, Logistic Models, Survival Analysis, Peripheral Vascular Diseases, Aortic Aneurysm, Abdominal, Age Distribution, Sex Distribution, Risk Assessment, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks